Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,277 publicly listed stocks with a combined market cap of $1.95 Trillion. CNS Pharmaceuticals Inc leads the sector with a market cap of $7.55 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$1.95 Trillion
Companies Listed
1,277
Largest Company
CNS Pharmaceuticals Inc
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1051 |
CNS Pharmaceuticals Inc
NASDAQ:CNSP |
$7.55 Million | $7.55 Million | USA | $5.82 | +19.94% | +7.52% | 231.50K |
| 1052 |
Synlogic Inc
NASDAQ:SYBX |
$7.49 Million | $7.49 Million | USA | $1.20 | +4.35% | +70.24% | 3.92 Million |
| 1053 |
Aptorum Group Ltd Class A
NASDAQ:APM |
$7.36 Million | $7.36 Million | USA | $8.32 | -2.92% | +1101.62% | 4.93 Million |
| 1054 |
MetaVia Inc.
NASDAQ:MTVA |
$7.33 Million | $7.33 Million | USA | $1.42 | -1.39% | -5.96% | 11.68 Million |
| 1055 |
Ascelia Pharma AB (publ)
ST:ACE |
$7.28 Million | Skr67.62 Million | Sweden | Skr0.53 | +4.51% | +4.72% | 103.98 Million |
| 1056 |
Aspire BioPharma, Inc.
NASDAQ:ASBP |
$7.27 Million | $7.27 Million | USA | $6.52 | -2.98% | -9.57% | 1.58 Million |
| 1057 |
Akari Therapeutics PLC
NASDAQ:AKTX |
$7.15 Million | $7.15 Million | USA | $7.86 | -1.75% | -15.48% | 1.65 Million |
| 1058 |
Modus Therapeutics Holding AB
ST:MODTX |
$6.98 Million | Skr64.86 Million | Sweden | Skr0.37 | +8.21% | +2.79% | 5.75 Million |
| 1059 |
Addex Therapeutics Ltd
SW:ADXN |
$6.98 Million | CHF5.52 Million | Switzerland | CHF0.04 | +3.45% | +0.00% | 3.30 Million |
| 1060 |
TME Pharma N.V.
PA:ALTME |
$6.89 Million | €5.89 Million | France | €0.06 | -0.16% | +4.33% | 2.47 Million |
| 1061 |
Traws Pharma Inc
NASDAQ:TRAW |
$6.85 Million | $6.85 Million | USA | $0.45 | +2.02% | -13.46% | 3.76 Million |
| 1062 |
TNF Pharmaceuticals, Inc.
NASDAQ:TNFA |
$6.80 Million | $6.80 Million | USA | $3.68 | -7.31% | -12.38% | 74.17 Million |
| 1063 |
Pure Biologics Spólka Akcyjna
WAR:PUR |
$6.77 Million | zł24.59 Million | Poland | zł2.17 | +0.00% | +0.46% | 2.07 Million |
| 1064 |
Imunon Inc
NASDAQ:IMNN |
$6.68 Million | $6.68 Million | USA | $1.59 | -0.63% | -4.22% | 5.35 Million |
| 1065 |
ONCODES.PREC.MED. EO-34
F:ZR8 |
$6.60 Million | €5.64 Million | Germany | €0.30 | +0.68% | +0.34% | 0.00 |
| 1066 |
Addex Therapeutics Ltd
NASDAQ:ADXN |
$6.58 Million | $6.58 Million | USA | $5.20 | -7.06% | -11.64% | 38.21K |
| 1067 |
Genprex Inc
NASDAQ:GNPX |
$6.46 Million | $6.46 Million | USA | $5.99 | -1.16% | -20.03% | 3.49 Million |
| 1068 |
Plant Advanced Technologies SA
PA:ALPAT |
$6.45 Million | €5.52 Million | France | €4.90 | +0.41% | -26.87% | 10.85K |
| 1069 |
Immuron Ltd ADR
NASDAQ:IMRN |
$6.45 Million | $6.45 Million | USA | $0.88 | +0.40% | +6.82% | 689.90K |
| 1070 |
Adial Pharmaceuticals Inc
NASDAQ:ADIL |
$6.39 Million | $6.39 Million | USA | $3.34 | +1.52% | +24.63% | 1.05 Million |
| 1071 |
Pulmatrix Inc
NASDAQ:PULM |
$6.35 Million | $6.35 Million | USA | $1.74 | +2.35% | -1.69% | 492.01K |
| 1072 |
TME PHARM.CONF.IPO EO 1-
F:0N6A |
$6.33 Million | €5.41 Million | Germany | €0.06 | +0.88% | +0.88% | 0.00 |
| 1073 |
Marvel Biosciences Corp
V:MRVL |
$6.29 Million | CA$8.70 Million | Canada | CA$0.15 | -9.09% | +0.00% | 1.43 Million |
| 1074 |
Pila Pharma AB
ST:PILA |
$6.27 Million | Skr58.24 Million | Sweden | Skr1.28 | +7.14% | +0.79% | 941.49K |
| 1075 |
Can Fite Biopharma Ltd ADR
NYSE MKT:CANF |
$6.23 Million | $6.23 Million | USA | $2.91 | -1.69% | -8.20% | 734.49K |
| 1076 |
PharmaCyte Biotech Inc
NASDAQ:PMCB |
$6.18 Million | $6.18 Million | USA | $0.58 | -4.00% | -4.76% | 2.83 Million |
| 1077 |
Titan Pharmaceuticals Inc
NASDAQ:TTNP |
$6.13 Million | $6.13 Million | USA | $4.61 | +0.00% | +7.63% | 2.76 Million |
| 1078 |
Reviva Pharmaceuticals Holdings Inc.
NASDAQ:RVPH |
$6.02 Million | $6.02 Million | USA | $0.47 | +17.47% | +4.42% | 763.04K |
| 1079 |
Can Fite Biopharma Ltd
TA:CANF |
$5.86 Million | ILA2.18 Billion | Israel | ILA509.70 | +1.94% | -3.65% | 1.11 Million |
| 1080 |
INVEX Therapeutics Ltd
AU:IXC |
$5.85 Million | AU$8.27 Million | Australia | AU$0.11 | +0.00% | -8.33% | 738.50K |
| 1081 |
Curanex Pharmaceuticals Inc Common Stock
NASDAQ:CURX |
$5.82 Million | $5.82 Million | USA | $0.21 | +7.43% | +2.60% | 1.68 Million |
| 1082 |
Processa Pharmaceuticals Inc
NASDAQ:PCSA |
$5.72 Million | $5.72 Million | USA | $2.15 | +5.39% | -25.09% | 12.97 Million |
| 1083 |
Clearmind Medicine Inc. Common Shares
NASDAQ:CMND |
$5.61 Million | $5.61 Million | USA | $1.69 | +4.32% | +1.81% | 21.80 Million |
| 1084 |
NuCana PLC
NASDAQ:NCNA |
$5.49 Million | $5.49 Million | USA | $1.32 | +4.76% | -0.75% | 1.30 Million |
| 1085 |
Bioatla Inc
NASDAQ:BCAB |
$5.46 Million | $5.46 Million | USA | $3.29 | -2.66% | -4.91% | 1.08 Million |
| 1086 |
BetterLife Pharma Inc
F:NPAU |
$5.42 Million | €4.64 Million | Germany | €0.07 | +104.55% | +117.74% | 1.02K |
| 1087 |
Adalta Ltd
AU:1AD |
$5.41 Million | AU$7.65 Million | Australia | AU$0.00 | +0.00% | +0.00% | 47.15 Million |
| 1088 |
Combigene AB
ST:COMBI |
$5.24 Million | Skr48.71 Million | Sweden | Skr2.46 | +1.23% | +0.00% | 71.17K |
| 1089 |
BioRestorative Therapies Inc
NASDAQ:BRTX |
$5.22 Million | $5.22 Million | USA | $0.20 | -9.22% | -34.48% | 8.93 Million |
| 1090 |
Aptevo Therapeutics Inc
NASDAQ:APVO |
$5.12 Million | $5.12 Million | USA | $4.11 | -0.48% | -5.95% | 1.96 Million |
| 1091 |
Quantum Genomics SA
PA:ALQGC |
$5.03 Million | €4.30 Million | France | €0.07 | +0.00% | +0.00% | 0.00 |
| 1092 |
Xenetic Biosciences Inc
NASDAQ:XBIO |
$4.98 Million | $4.98 Million | USA | $2.54 | -0.59% | -5.59% | 417.62K |
| 1093 |
Bio-Gene Technology Ltd
AU:BGT |
$4.96 Million | AU$7.02 Million | Australia | AU$0.02 | +27.78% | +35.29% | 9.27 Million |
| 1094 |
Vectus Biosystems Ltd
AU:VBS |
$4.91 Million | AU$6.95 Million | Australia | AU$0.13 | +0.00% | -13.33% | 678.78K |
| 1095 |
Moolec Science SA Ordinary Shares
NASDAQ:MLEC |
$4.89 Million | $4.89 Million | USA | $6.73 | -6.53% | -6.27% | 280.46K |
| 1096 |
Jaguar Animal Health Inc
NASDAQ:JAGX |
$4.86 Million | $4.86 Million | USA | $1.00 | -3.85% | -2.91% | 1.77 Million |
| 1097 |
Bio Green Med Solution, Inc.
NASDAQ:BGMS |
$4.86 Million | $4.86 Million | USA | $0.89 | -2.50% | +1.70% | 2.36 Million |
| 1098 |
Purple Biotech Ltd
TA:PPBT |
$4.84 Million | ILA1.81 Billion | Israel | ILA1.00 | +0.00% | +0.00% | 6.06 Million |
| 1099 |
BRITANNIA LIFE SCIENCES
F:L020 |
$4.84 Million | €4.14 Million | Germany | €0.03 | +0.00% | -10.53% | 0.00 |
| 1100 |
Salarius Pharmaceuticals Inc
NASDAQ:SLRX |
$4.81 Million | $4.81 Million | USA | $0.82 | -2.40% | +26.59% | 14.81 Million |
| 1101 |
Qualigen Therapeutics Inc
NASDAQ:QLGN |
$4.74 Million | $4.74 Million | USA | $2.33 | +0.30% | -8.98% | 2.43 Million |
| 1102 |
Silo Pharma Inc
NASDAQ:SILO |
$4.73 Million | $4.73 Million | USA | $4.19 | -1.41% | -6.05% | 8.32 Million |
| 1103 |
XTL Biopharmaceuticals Ltd
TA:XTLB |
$4.73 Million | ILA1.76 Billion | Israel | ILA2.00 | +0.00% | +0.00% | 84.48 Million |
| 1104 |
Dermata Therapeutics Inc
NASDAQ:DRMA |
$4.71 Million | $4.71 Million | USA | $1.17 | -0.85% | -7.14% | 1.82 Million |
| 1105 |
2cureX AB
ST:2CUREX |
$4.67 Million | Skr43.38 Million | Sweden | Skr1.73 | -0.12% | -4.00% | 413.85K |
| 1106 |
Exact Therapeutics AS
OL:EXTX |
$4.66 Million | Nkr44.28 Million | Norway | Nkr0.70 | +4.48% | +4.48% | 635.37K |
| 1107 |
Liminatus Pharma, Inc. Class A Common Stock
NASDAQ:LIMN |
$4.62 Million | $4.62 Million | USA | $0.10 | +0.88% | -13.23% | 1.37 Billion |
| 1108 |
Cardio Diagnostics Holdings Inc
NASDAQ:CDIO |
$4.62 Million | $4.62 Million | USA | $1.56 | -0.64% | -4.29% | 1.93 Million |
| 1109 |
Fluicell AB
ST:FLUI |
$4.60 Million | Skr42.72 Million | Sweden | Skr31.10 | -1.27% | -0.96% | 83.19K |
| 1110 |
Alaunos Therapeutics Inc
NASDAQ:TCRT |
$4.52 Million | $4.52 Million | USA | $1.88 | +0.00% | -2.08% | 352.46K |
| 1111 |
Aptose Biosciences Inc
TO:APS |
$4.43 Million | CA$6.13 Million | Canada | CA$2.40 | +0.00% | +9.09% | 85.56K |
| 1112 |
COLLPLANT BIOTECH. IS-01
F:CPT |
$4.34 Million | €3.71 Million | Germany | €0.27 | +0.00% | +0.00% | 0.00 |
| 1113 |
CASI Pharmaceuticals Inc
NASDAQ:CASI |
$4.26 Million | $4.26 Million | USA | $0.24 | +17.06% | -68.82% | 11.66 Million |
| 1114 |
Zelira Therapeutics Ltd
AU:ZLD |
$4.21 Million | AU$5.95 Million | Australia | AU$0.50 | +0.00% | +0.00% | 0.00 |
| 1115 |
Biophytis S.A.
NASDAQ:BPTSY |
$4.19 Million | $4.19 Million | USA | $2.08 | +0.00% | +0.00% | 0.00 |
| 1116 |
Inhalerx Ltd
AU:IRX |
$4.18 Million | AU$5.91 Million | Australia | AU$0.02 | +4.35% | +33.33% | 1.37 Million |
| 1117 |
Transcode Therapeutics Inc
NASDAQ:RNAZ |
$4.18 Million | $4.18 Million | USA | $4.56 | -13.14% | -37.10% | 672.49K |
| 1118 |
Kineta, Inc.
NASDAQ:KANT |
$4.12 Million | $4.12 Million | USA | $0.34 | +0.00% | +0.00% | 0.00 |
| 1119 |
Acurx Pharmaceuticals LLC
NASDAQ:ACXP |
$4.11 Million | $4.11 Million | USA | $1.44 | +1.41% | -0.69% | 2.28 Million |
| 1120 |
Matinas BioPharma Holdings Inc
NYSE MKT:MTNB |
$4.09 Million | $4.09 Million | USA | $0.70 | +5.09% | +23.06% | 7.31 Million |
| 1121 |
Galmed Pharmaceuticals Ltd
NASDAQ:GLMD |
$4.03 Million | $4.03 Million | USA | $0.62 | +3.67% | +12.30% | 19.63 Million |
| 1122 |
DMD Digital Health Connections Group Inc
NASDAQ:APTOF |
$4.01 Million | $4.01 Million | USA | $1.69 | +0.00% | +9.03% | 52.70K |
| 1123 |
NLS Pharmaceutics AG
NASDAQ:NLSP |
$3.97 Million | $3.97 Million | USA | $0.76 | +2.97% | -52.08% | 43.52 Million |
| 1124 |
International Biotechnology Trust plc
LSE:IBT |
$3.96 Million | GBX32.54 Billion | UK | GBX1020.00 | -1.92% | -7.69% | 3.32 Million |
| 1125 |
Ensysce Biosciences Inc
NASDAQ:ENSC |
$3.89 Million | $3.89 Million | USA | $0.25 | -1.56% | -7.19% | 27.00 Million |
| 1126 |
Tissue Repair Ltd
AU:TRP |
$3.85 Million | AU$5.44 Million | Australia | AU$0.09 | +8.43% | +12.50% | 2.59 Million |
| 1127 |
Mustang Bio Inc
NASDAQ:MBIO |
$3.84 Million | $3.84 Million | USA | $0.57 | -3.97% | +0.02% | 806.06K |
| 1128 |
Biotron Ltd
AU:BIT |
$3.82 Million | AU$5.40 Million | Australia | AU$0.00 | +0.00% | -20.00% | 29.87 Million |
| 1129 |
Soligenix Inc.
NASDAQ:SNGX |
$3.77 Million | $3.77 Million | USA | $0.37 | -0.29% | +1.47% | 9.06 Million |
| 1130 |
BIOVAXYS TECHNOLOGY CORP.
F:5LB |
$3.75 Million | €3.20 Million | Germany | €0.15 | +928.28% | +1320.00% | 30.67K |
| 1131 |
2CUREX AB SEK-10
F:2QE |
$3.63 Million | €3.10 Million | Germany | €0.15 | -1.05% | -5.27% | 0.00 |
| 1132 |
Evogene
TA:EVGN |
$3.60 Million | ILA1.34 Billion | Israel | ILA154.10 | +1.31% | -15.19% | 3.01 Million |
| 1133 |
GLOW LIFETECH CORP.
F:9DO |
$3.60 Million | €3.08 Million | Germany | €0.02 | -5.56% | -5.56% | 0.00 |
| 1134 |
XORTX Therapeutics Inc
V:XRTX |
$3.55 Million | CA$4.91 Million | Canada | CA$2.84 | -3.73% | -3.07% | 26.79K |
| 1135 |
Avacta Group PLC
LSE:AVCT |
$3.54 Million | GBX29.10 Billion | UK | GBX66.50 | -2.06% | -3.62% | 19.02 Million |
| 1136 |
Revelation Biosciences Inc
NASDAQ:REVB |
$3.53 Million | $3.53 Million | USA | $0.95 | -4.55% | -11.21% | 1.12 Million |
| 1137 |
Conduit Pharmaceuticals Inc.
NASDAQ:CDT |
$3.50 Million | $3.50 Million | USA | $2.93 | +9.33% | -10.40% | 6.71 Million |
| 1138 |
Collplant Biotechnologies Ltd
NASDAQ:CLGN |
$3.49 Million | $3.49 Million | USA | $0.27 | -9.04% | -12.68% | 734.32K |
| 1139 |
Alzamend Neuro Inc
NASDAQ:ALZN |
$3.43 Million | $3.43 Million | USA | $1.31 | -2.96% | +3.97% | 5.28 Million |
| 1140 |
Guard Therapeutics International AB
ST:GUARD |
$3.38 Million | Skr31.42 Million | Sweden | Skr1.56 | -2.01% | +11.29% | 346.81K |
| 1141 |
PreveCeutical Medical Inc
F:18H |
$3.34 Million | €2.85 Million | Germany | €0.01 | -54.55% | -77.27% | 356.50K |
| 1142 |
BIOMIND LABS INC.
F:3XI |
$3.31 Million | €2.83 Million | Germany | €0.04 | +0.00% | -30.48% | 10.50K |
| 1143 |
Azitra Inc
NYSE MKT:AZTR |
$3.30 Million | $3.30 Million | USA | $0.20 | -3.77% | +10.57% | 13.26 Million |
| 1144 |
Kane Biotech Inc
V:KNE |
$3.29 Million | CA$4.55 Million | Canada | CA$0.03 | +0.00% | +0.00% | 1.74 Million |
| 1145 |
Jupiter Neurosciences, Inc. Common Stock
NASDAQ:JUNS |
$3.27 Million | $3.27 Million | USA | $0.09 | -7.69% | -41.18% | 428.27 Million |
| 1146 |
Iterum Therapeutics PLC
NASDAQ:ITRM |
$3.20 Million | $3.20 Million | USA | $0.06 | -12.01% | +9.27% | 3.77 Million |
| 1147 |
Psyence Biomedical Ltd. Common Shares
NASDAQ:PBM |
$3.16 Million | $3.16 Million | USA | $3.17 | -5.65% | +12.41% | 1.67 Million |
| 1148 |
60 Degrees Pharmaceuticals, Inc. Common Stock
NASDAQ:SXTP |
$3.09 Million | $3.09 Million | USA | $1.17 | -6.40% | -21.48% | 2.24 Million |
| 1149 |
ValiRx plc
LSE:VAL |
$3.05 Million | £2.27 Million | UK | £0.15 | +0.00% | -6.25% | 254.54 Million |
| 1150 |
Enlivex Therapeutics Ltd
TA:ENLV |
$2.98 Million | ILA1.11 Billion | Israel | ILA4.68 | -31.78% | +549.46% | 4.83 Million |
| 1151 |
Innovotech Inc
V:IOT |
$2.95 Million | CA$4.08 Million | Canada | CA$0.08 | -6.25% | -6.25% | 1.19 Million |
| 1152 |
Opthea Limited
NASDAQ:OPTEY |
$2.94 Million | $2.94 Million | USA | $0.02 | +0.00% | -22.17% | 358.37K |
| 1153 |
ACRUX Ltd
AU:ACR |
$2.91 Million | AU$4.11 Million | Australia | AU$0.01 | +0.00% | -16.67% | 15.31 Million |
| 1154 |
LOBE SCIENCES LTD
F:6YX0 |
$2.90 Million | €2.48 Million | Germany | €0.03 | +21.95% | -5.66% | 0.00 |
| 1155 |
Alligator Bioscience AB
ST:ATORX |
$2.89 Million | Skr26.88 Million | Sweden | Skr0.04 | +4.14% | -15.08% | 297.63 Million |
| 1156 |
Indaptus Therapeutics Inc
NASDAQ:INDP |
$2.89 Million | $2.89 Million | USA | $1.29 | -10.42% | -53.43% | 2.28 Million |
| 1157 |
Scisparc Ltd
NASDAQ:SPRC |
$2.85 Million | $2.85 Million | USA | $7.12 | -18.16% | +24.48% | 9.58 Million |
| 1158 |
Unity Biotechnology Inc
NASDAQ:UBX |
$2.75 Million | $2.75 Million | USA | $0.16 | +0.00% | +0.00% | 1.42 Million |
| 1159 |
Omega Therapeutics Inc
NASDAQ:OMGA |
$2.69 Million | $2.69 Million | USA | $0.05 | +0.00% | +0.00% | 105.64K |
| 1160 |
Calidi Biotherapeutics Inc.
NYSE MKT:CLDI |
$2.68 Million | $2.68 Million | USA | $0.18 | -8.29% | -7.32% | 212.03 Million |
| 1161 |
Creative Medical Technology Holdings Inc
NASDAQ:CELZ |
$2.45 Million | $2.45 Million | USA | $0.66 | -13.12% | -18.08% | 199.56 Million |
| 1162 |
Palatin Technologies Inc
NYSE MKT:PTN |
$2.45 Million | $2.45 Million | USA | $23.00 | +4.59% | +0.00% | 243.66K |
| 1163 |
Quest PharmaTech Inc
V:QPT |
$2.45 Million | CA$3.38 Million | Canada | CA$0.02 | -20.00% | -20.00% | 2.32 Million |
| 1164 |
GRI Bio Inc.
NASDAQ:GRI |
$2.44 Million | $2.44 Million | USA | $1.38 | -2.13% | -8.00% | 809.26K |
| 1165 |
Oragenics Inc
NYSE MKT:OGEN |
$2.42 Million | $2.42 Million | USA | $0.60 | +1.69% | +5.13% | 1.11 Million |
| 1166 |
Propanc Biopharma, Inc. Common Stock
NASDAQ:PPCB |
$2.30 Million | $2.30 Million | USA | $1.01 | -2.88% | -30.34% | 61.24 Million |
| 1167 |
Green Cross Holdings Preference Shares
KO:005257 |
$2.29 Million | ₩3.39 Billion | Korea | ₩14070.00 | +0.50% | -9.34% | 11.84K |
| 1168 |
HCW Biologics Inc
NASDAQ:HCWB |
$2.29 Million | $2.29 Million | USA | $3.20 | +1.59% | +11.11% | 1.88 Million |
| 1169 |
Decoy Therapeutics Inc.
NASDAQ:DCOY |
$2.19 Million | $2.19 Million | USA | $4.11 | +4.85% | -16.80% | 14.74 Million |
| 1170 |
Clearside Biomedical Inc
NASDAQ:CLSD |
$2.15 Million | $2.15 Million | USA | $0.41 | -26.96% | -85.66% | 12.52 Million |
| 1171 |
Moleculin Biotech Inc
NASDAQ:MBRX |
$2.13 Million | $2.13 Million | USA | $0.40 | -60.78% | -80.77% | 30.17 Million |
| 1172 |
Cynata Therapeutics Ltd
AU:CYP |
$2.02 Million | AU$2.85 Million | Australia | AU$0.01 | +0.00% | -7.69% | 28.51 Million |
| 1173 |
Abpro Holdings, Inc.
NYSE:ABP |
$2.00 Million | $2.00 Million | USA | $5.70 | -0.87% | -1.72% | 165.25K |
| 1174 |
Kancera AB (publ)
ST:KAN |
$1.98 Million | Skr18.44 Million | Sweden | Skr0.15 | -23.82% | -37.24% | 30.49 Million |
| 1175 |
PALATIN TECHS DL-01
F:PTN |
$1.97 Million | €1.68 Million | Germany | €3.30 | +0.00% | +0.00% | 0.00 |
| 1176 |
Medigene AG
XETRA:MDG1 |
$1.97 Million | €1.68 Million | Germany | €0.13 | +0.00% | +0.00% | 189.47K |
| 1177 |
Plantarc Bio Ltd
TA:PLNT |
$1.96 Million | ILA731.02 Million | Israel | ILA220.90 | +0.00% | +1.33% | 217.47K |
| 1178 |
Prostemics Co. Ltd
KQ:203690 |
$1.88 Million | ₩2.78 Billion | Korea | ₩139.00 | +0.00% | +0.00% | 3.45 Million |
| 1179 |
LakeShore Biopharma Co., Ltd
NYSE:LSBCF |
$1.85 Million | $1.85 Million | USA | $0.07 | +0.00% | +0.00% | 55.20K |
| 1180 |
Rakovina Therapeutics Inc
V:RKV |
$1.84 Million | CA$2.54 Million | Canada | CA$0.12 | +14.29% | +9.09% | 558.60K |
| 1181 |
Medesis Pharma SA
PA:ALMDP |
$1.80 Million | €1.54 Million | France | €0.35 | +0.00% | +0.00% | 0.00 |
| 1182 |
Elevai Labs, Inc. Common Stock
NASDAQ:ELAB |
$1.79 Million | $1.79 Million | USA | $0.92 | -2.78% | -2.74% | 113.80 Million |
| 1183 |
Anatara Lifesciences Ltd
AU:ANR |
$1.75 Million | AU$2.47 Million | Australia | AU$0.01 | +0.00% | -9.09% | 1.34 Million |
| 1184 |
Chimeric Therapeutics Ltd
AU:CHM |
$1.58 Million | AU$2.23 Million | Australia | AU$0.04 | -2.27% | +10.26% | 6.50 Million |
| 1185 |
BioSenic S.A.
BR:BIOS |
$1.57 Million | €1.34 Million | Belgium | €0.00 | +0.00% | +0.00% | 3.25 Million |
| 1186 |
Oncternal Therapeutics Inc
NASDAQ:ONCT |
$1.56 Million | $1.56 Million | USA | $0.53 | +0.00% | +0.00% | 0.00 |
| 1187 |
Artelo Biosciences Inc
NASDAQ:ARTL |
$1.55 Million | $1.55 Million | USA | $0.77 | +1.96% | -27.36% | 5.76 Million |
| 1188 |
GEMINA LABS LTD
F:8I7 |
$1.53 Million | €1.31 Million | Germany | €0.02 | +0.00% | -16.28% | 4.50K |
| 1189 |
ExpreS2ion Biotech Holding AB
ST:EXPRS2 |
$1.52 Million | Skr14.13 Million | Sweden | Skr1.43 | +1.42% | +4.38% | 1.18 Million |
| 1190 |
Bone Biologics Corp
NASDAQ:BBLG |
$1.52 Million | $1.52 Million | USA | $0.85 | -1.67% | -21.69% | 1.09 Million |
| 1191 |
Biosergen AS
ST:BIOSGN |
$1.52 Million | Skr14.09 Million | Sweden | Skr6.00 | +0.00% | -10.45% | 118.80K |
| 1192 |
GeoVax Labs Inc
NASDAQ:GOVX |
$1.51 Million | $1.51 Million | USA | $0.68 | -3.05% | -18.90% | 5.44 Million |
| 1193 |
Stayble Therapeutics AB
ST:STABL |
$1.42 Million | Skr13.19 Million | Sweden | Skr0.21 | +0.00% | +0.00% | 148.88 Million |
| 1194 |
Appili Therapeutics Inc
TO:APLI |
$1.39 Million | CA$1.93 Million | Canada | CA$0.02 | +50.00% | +0.00% | 934.13K |
| 1195 |
Scinai Immunotherapeutics Ltd
NASDAQ:SCNI |
$1.34 Million | $1.34 Million | USA | $0.27 | -1.09% | +10.48% | 11.56 Million |
| 1196 |
Hepion Pharmaceuticals Inc
NASDAQ:HEPA |
$1.34 Million | $1.34 Million | USA | $0.05 | -0.22% | +0.88% | 483.58K |
| 1197 |
Purple Biotech
NASDAQ:PPBT |
$1.30 Million | $1.30 Million | USA | $1.40 | +2.19% | +0.72% | 690.36K |
| 1198 |
Virax Biolabs Group Limited Ordinary Shares
NASDAQ:VRAX |
$1.27 Million | $1.27 Million | USA | $2.62 | -6.43% | -17.87% | 90.63 Million |
| 1199 |
Biomx Inc
NYSE MKT:PHGE |
$1.25 Million | $1.25 Million | USA | $0.82 | +10.57% | +39.85% | 249.67 Million |
| 1200 |
Scancell Hldgs Plc
LSE:SCLP |
$1.23 Million | GBX10.12 Billion | UK | GBX9.75 | -0.51% | -7.14% | 110.04 Million |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries